Replies to post #4320 on NorthWest Biotherapeutics Inc (NWBO)

[betweenthelines]

OK, so I kind of contradicted myself. My thinking was more to say that they do not have any sort of data set yet. One data point (datum) does not constitute "data". If they have 2 data points it may technically be 'data', but really I am referring to a body of evidence as the word is typically used to describe. I think NWBO was expecting to have "data" by now when they announced their trial beginning last June. I believe they were referring to several data points or at least enough to see any sort of preliminary trend. We are just talking semantics now, but I think you understand what I meant.

[tradingintheusa]

They would not submit an ASCO abstract without having data. The guidelines are crystal clear. Only papers which can be backed up by statistically significant data will be approved. And data needs to be available at the time of submission. You can't state it will be provided later etc. They have to provide results in the abstract submission.

To me it's perfectly clear. They do have good data in their hands for Direct.